Michael P. Doyle
13Patents
8h-index
24Co-inventors
72Inventor score
Filing activity: Jul 27, 1990 → Jun 24, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6670323B1 | Reduced side-effect hemoglobin compositions | Human Necessities | 78 | Expired |
| US5965128A | Control of enterohemorrhagic E. coli 0157:H7 in cattle by probiotic bacteria and specific strains of E. coli | Emerging Cross-Sectional Technologies | 55 | Expired |
| US7211560B2 | Reduced side-effect hemoglobin compositions | Human Necessities | 47 | Expired |
| US7575744B2 | Composition and method for inhibition of microorganisms | Emerging Cross-Sectional Technologies | 12 | Expired |
| US5302388A | Control of campylobacter jejuni colonization | Emerging Cross-Sectional Technologies | 12 | Expired |
| US5354661A | Monoclonal antibody to enterohemorrhagic Escherichia coli 0157:H7 and 026:H11 and method for detection | Emerging Cross-Sectional Technologies | 12 | Expired |
| US5168063A | Monoclonal antibody to enterohemorrhagic Escherichia coli 0157:H7 and 026:H11 | Emerging Cross-Sectional Technologies | 11 | Expired |
| US8137705B2 | Control of enterohemorrhagic E. coli in farm animal drinking water | Human Necessities | 10 | Active |
| US8722123B2 | Antimicrobial composition and use as food treatment | Human Necessities | 3 | Active |
| US7361497B2 | Probiotic bacteria | Emerging Cross-Sectional Technologies | 0 | Expired |
| US11377420B2 | Compositions and methods for making donor-acceptor azetines | Performing Operations; Transporting | 0 | Active |
| US8440448B2 | Composition and method for inhibition of microorganisms | Emerging Cross-Sectional Technologies | 0 | Active |
| US7744868B2 | Composition and method for inhibiting Salmonella and Campylobacter colonization in poultry | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.